Circio logoCircio logo

  • About
    About
    Close
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
    circRNA
    Close
      • Circio AB
      • circVec platform
  • Clinical programs
    Clinical programs
    Close
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
    Investors
    Close
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
    Media
    Close
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    Contacts
    Close
      • Offices
      • Investors & Media
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2021
    • 2023
    • 2022
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    December 23, 2021
    Press release - Regulatory

    Targovax ASA issues options to employees

    December 22, 2021
    Press release - Regulatory

    Targovax ASA – Registration of share capital increase pertaining to the Rights Issue

    December 20, 2021
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insider share purchase

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insiders share purchase

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insiders share purchase

    December 15, 2021
    Press release - Regulatory

    Targovax awarded NOK 9.8m research grant by the Research Council of Norway towards the TG mutant RAS program

    December 15, 2021
    Press release - Regulatory

    Targovax ASA – Final results of the rights issue

    December 14, 2021
    Press release - Regulatory

    Targovax ASA – Preliminary results of the rights issue

    December 14, 2021
    Press release - Regulatory

    Targovax ASA – The subscription period for the rights issue expires today

    December 13, 2021
    Press release - Non-regulatory

    Targovax to present at DNB’s 12[th] Nordic Healthcare Conference

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Last day of trading in subscription rights

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    December 5, 2021
    Press release - Regulatory

    Shareholder disclosure by Radforsk Investeringsstiftelse

    December 1, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Commencement of the subscription period for the rights issue

    November 29, 2021
    Press release - Regulatory

    Targovax ASA – Approval and publication of the prospectus for the rights issue

    November 26, 2021
    Press release - Regulatory

    TRVX – Ex. subscription rights today

    November 25, 2021
    Press release - Regulatory

    Targovax ASA – Rights issue approved by the extraordinary general meeting

    November 24, 2021
    Press release - Regulatory

    Targovax ASA – Updated key information relating to the preferential rights issue

    November 24, 2021
    Press release - Regulatory

    Targovax ASA – Terms of the fully underwritten rights issue

    November 18, 2021
    Press release - Non-regulatory

    Targovax invites to webcast presentation in Norwegian

    November 9, 2021
    Press release - Non-regulatory

    Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

    November 4, 2021
    Press release - Regulatory

    Targovax ASA – Key information relating to the preferential rights issue

    November 4, 2021
    Press release - Regulatory

    Targovax ASA – Notice of extraordinary general meeting – Fully underwritten rights issue

    November 4, 2021
    Press release - Regulatory

    Targovax ASA: Third quarter 2021 results

    October 27, 2021
    Press release - Regulatory

    Targovax ASA: PDMR notices

    October 27, 2021
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s third quarter 2021 results, Thursday 4 November

    October 25, 2021
    Press release - Non-regulatory

    Targovax: Presentation material for today’s webcast

    October 22, 2021
    Press release - Non-regulatory

    Targovax invites to webcast presentation on Xtrainvestor

    October 21, 2021
    Press release - Regulatory

    Targovax ASA: GRANT OF SHARE OPTIONS

    October 20, 2021
    Press release - Regulatory

    Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

    October 19, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    October 6, 2021
    Press release - Non-regulatory

    Targovax ASA: Two abstracts accepted at the SITC Congress

    October 3, 2021
    Press release - Regulatory

    Targovax ASA issues options to new member of management

    September 30, 2021
    Press release - Non-regulatory

    Targovax ASA appoints Ola Melin as Head of Manufacturing

    September 24, 2021
    Press release - Non-regulatory

    Targovax granted European Patent for ONCOS-102 in combination with chemotherapy

    September 16, 2021
    Press release - Non-regulatory

    Targovax ASA: Poster at European Society for Medical Oncology (ESMO)

    August 27, 2021
    Press release - Non-regulatory

    Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress

    August 18, 2021
    Press release - Regulatory

    Targovax ASA: second quarter and first half year 2021 results

    August 16, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming scientific conferences

    August 9, 2021
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2021 results, Wednesday 18 August

    July 9, 2021
    Press release - Regulatory

    Targovax announces resignation of Chief Financial Officer, Torbjørn Furuseth

    July 2, 2021
    Press release - Regulatory

    Targovax ASA issues options to new member of management

    July 1, 2021
    Press release - Regulatory

    Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer

    June 28, 2021
    Press release - Regulatory

    Targovax to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition

    June 22, 2021
    Press release - Regulatory

    Targovax receives Fast Track designation for ONCOS-102 in melanoma

    June 17, 2021
    Press release - Regulatory

    Targovax announces completed enrollment in the phase 1/2 trial with ONCOS-102 in combination with durvalumab in patients with advanced colorectal cancer with peritoneal malignancies

    June 14, 2021
    Press release - Regulatory

    Targovax releases presentations of ONCOS-102 mesothelioma 24-month data

    June 10, 2021
    Press release - Regulatory

    Targovax’s ONCOS-102 mesothelioma 24-month data shows class-leading median overall survival

    May 26, 2021
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following the settlement of RSUs

    May 21, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming investor and scientific conferences

    May 19, 2021
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

    May 18, 2021
    Press release - Regulatory

    Targovax ASA: Resolution to increase the share capital following exercise of RSUs

    May 6, 2021
    Press release - Regulatory

    Targovax ASA: First quarter 2021 results

    April 27, 2021
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’s first quarter 2021 results, Thursday 6 May

    March 18, 2021
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    March 17, 2021
    Press release - Non-regulatory

    Targovax ASA announces new member of the Board

    March 17, 2021
    Press release - Non-regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    March 9, 2021
    Press release - Non-regulatory

    Targovax granted US Patent for ONCOS-102 in combination with checkpoint inhibitors

    March 8, 2021
    Press release - Non-regulatory

    Targovax to present and attend at upcoming investor and scientific conferences

    March 4, 2021
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of options

    March 1, 2021
    Press release - Regulatory

    Targovax ASA: Exercise of options under LTI program and resolution to increase the share capital

    February 24, 2021
    Press release - Non-regulatory

    Targovax: Proposal for Remuneration Guidelines for Board and Executive Management

    February 23, 2021
    Press release - Non-regulatory

    Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up

    February 18, 2021
    Press release - Non-regulatory

    Reminder: Invitation to Targovax’s Capital Markets Day 18 February 2021

    February 18, 2021
    Press release - Regulatory

    Targovax ASA: Annual Report 2020

    February 18, 2021
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2020 results

    February 17, 2021
    Press release - Non-regulatory

    Notice of Annual General Meeting

    February 15, 2021
    Press release - Non-regulatory

    Targovax receives Fast-Track designation for ONCOS-102

    February 11, 2021
    Press release - Non-regulatory

    Agenda for Targovax’s Capital Markets Day 18 February 2021

    February 10, 2021
    Press release - Non-regulatory

    Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality

    February 9, 2021
    Press release - Non-regulatory

    SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102

    January 11, 2021
    Press release - Non-regulatory

    Targovax to present at the H.C. Wainwright Virtual BioConnect 2021 Conference

    January 6, 2021
    Press release - Non-regulatory

    Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Singapore

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    • PRINT
    • STAY CONNECTED
    • Cookies
    • Privacy policy